How many drugs treat Carcinoma of fallopian tube?

Drug Landscape tracks 5 marketed treatments for Carcinoma of fallopian tube (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/carcinoma-of-fallopian-tube.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Carcinoma of fallopian tube — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Carcinoma of fallopian tube (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Carcinoma of fallopian tube, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Taxol	paclitaxel	Pfizer	Microtubule Inhibitor [EPC]	Tubulin beta-3 chain	1992-01-01
Taxol	nab-paclitaxel	Pfizer	Microtubule Inhibitor	Tubulin beta-3 chain	1992-01-01
Abraxane	Abraxane	The First Affiliated Hospital with Nanjing Medical University		Multidrug resistance-associated protein 7, Bile salt export pump, Melanocortin receptor 5
Taxol	Taxol	M.D. Anderson Cancer Center		Multidrug resistance-associated protein 7, Bile salt export pump, Melanocortin receptor 5
Taxol	Nabpaclitaxel	Pfizer	Microtubule Inhibitor	Tubulin beta-3 chain	1992-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 3 drugs in Carcinoma of fallopian tube
M.D. Anderson Cancer Center · 1 drug in Carcinoma of fallopian tube
The First Affiliated Hospital with Nanjing Medical University · 1 drug in Carcinoma of fallopian tube

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Carcinoma of fallopian tube:

Cite this brief

Drug Landscape (2026). Carcinoma of fallopian tube — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/carcinoma-of-fallopian-tube. Accessed 2026-06-10.

Carcinoma of fallopian tube full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing